Specifically, the in vivo assay conducted in a mouse vitiligo model verified that, mice received Cxcr3-/- T cells develop minimal depigmentation, as do mice lacking Cxcl10 or treated with CXCL10-neutralizing antibody. This evidence concerns the gene CXCR3 and vitiligo.